Skip to Content
Webinar Recording

Zanubrutinib in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Recorded on: November 14, 2024

Gain insight from Kyle Skiermont, PharmD (Nebraska Medicine), into how zanubrutinib, with its proven efficacy and high potency, is transforming treatment for chronic lymphocytic leukemia and small lymphocytic lymphoma. Discover how its sustained BTK inhibition and dosing flexibility lead to personalized treatment strategies that enhance patient care across diverse subgroups.